J. Michael  Gonzalez-Campoy MD, PhD, FACE's portrait

J. Michael Gonzalez-Campoy MD, PhD, FACE

Medical Director and Chief Executive Officer
Minnesota Center for Obesity, Metabolism, and Endocrinology
Eagan, MN
Dr. Gonzalez-Campoy is a member of the EndocrineWeb Editorial Board.
He is a Senior Editor and oversees the obesity section on EndocrineWeb.

About J. Michael Gonzalez-Campoy MD, PhD, FACE

J. Michael Gonzalez-Campoy, MD, PhD, FACE is Medical Director and Chief Executive Officer of the Minnesota Center for Obesity, Metabolism and Endocrinology (MNCOME) in Eagan, Minnesota.  

Dr. Gonzalez-Campoy introduced bariatric endocrinology as a subspecialty, and is the principal editor of the premier textbook on this subject. He was instrumental in helping national professional organizations accept overweight, obesity and adiposopathy as primary treatment targets.  He helped create the certification examination for the American Board of Obesity Medicine, and received his certification with the first class of bariatric medicine specialists.

Dr. Gonzalez-Campoy is past member of the American College of Endocrinology Board of Trustees, and the American Association of Clinical Endocrinologists Board of Directors.  He is coauthor of guidelines for adiposopathy, overweight and obesity care with these, and other national organizations

Dr. Gonzalez-Campoy lectures nationally and internationally to advance bariatric endocrinology care.


National Diabetes Education Program (NDEP). Guiding Principles for Diabetes Care: For Health Care Professionals. NIH Publication No. 09-4343 NDEP-16. Revised April 2009.

Bays HE, Gonzalez-Campoy JM, Henry RR, Bergman DA. Kitabchi AE, Schorr AB. Rodbard HW. The Adiposopathy Working Group. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract. 2008;62(10):1474-83. Epub 2008 Aug 4.

Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, and Dixon J. Executive Summary Of The Recommendations Of The American Association Of Clinical Endocrinologists, The Obesity Society, And American Society For Metabolic & Bariatric Surgery Medical Guidelines For Clinical Practice For The Perioperative Nutritional, Metabolic, And Nonsurgical Support Of The Bariatric Surgery Patient. Endocr Pract. 2008;14(3):318-36.

Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, and Henry RR. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6(3): 343-368.

Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM, and Bank AJ. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. Vascular Medicine. 2007;12:311–318.

Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM. The effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Hypertens. 2007;20(7):777-83.

Minnesota Medical Association Obesity Task Force. How to Evaluate and Treat Obesity. Minnesota Medicine. 2005;88:40-46.

The Report of the Minnesota Medical Association Health Care Reform Task Force. Minnesota Medicine. 2005;88:Supplement.

Gonzalez-Campoy RC, Gonzalez-Campoy JM. Minnesota Diabetes Plan 2010. Minnesota Medicine. 2003;86:44-48.

Minnesota Diabetes Plan 2010. Recommendations from Minnesota’s Diabetes Community. Facilitated by the Minnesota Department of Health. September, 2003. www.health.state.mn.us/diabetes/2010plan

Hensrud D, Billington C, Blum HT, Gonzalez-Campoy JM, Ramsey S. ICSI Technology Assessment: Pharmacological Approaches to Weight Loss in Adults. 2003. http://www.icsi.org/knowledge/detail.asp?catID=107&itemID=785

Gonzalez-Campoy JM, Long C, Roberts D, Berndt T, Romero JC, Knox FG. Renal interstitial hydrostatic pressure and PGE2 in pressure natriuresis. Am J Physiol (Fluid Electrolyte Metabolism). 1991;260(5):F643-F649.

Gonzalez-Campoy JM, Awazu M, Granger JP, Haas JA, Romero JC, Knox FG. Blunted Pressure Natriuresis in the Brattleboro Diabetes Insipidus Rat. Hypertension. 1989;13:322-326.

Gonzalez-Campoy JM, Kachelski J, Burnett, Jr. JC, Granger JP, Romero JC, Knox FG. Proximal Tubule Response in Aldosterone Escape. Am J Physiol (Regulatory Integrative Comp. Physiol). 1989;256(1):R86-R90.

Chiou RK, Vessella RL, Elson MK, Clayman RV, Gonzalez-Campoy JM, Klicka MJ, Shafer RB, Lange PH. Localization of human renal cell carcinoma xenografts with a tumor-preferential monoclonal antibody.  Cancer Research. 1985;45:6140-6146.

Gonzalez-Campoy JM. Temporal and regional characteristics of cerebral vascular responses to sympathetic nerve stimulation. Abbreviated Reports by Research Participants in the Secondary Student Training Program. 1978;2:73-75, University of Iowa, Iowa City, Iowa.

Articles Written by J. Michael Gonzalez-Campoy MD, PhD, FACE

Bariatric Surgery
Many people with obesity can’t simply lose weight with healthy eating and physical activity, despite how hard they may try. Bariatric (obesity) surgery is performed to treat people who have morbid obesity.
Obesity in America: A Growing Concern
Obesity has become a serious health problem in the United States: nearly 35% of Americans have obesity. Obesity is not just a problem of “girth control”; it is now considered a chronic disease by leading medical associations.
Gastric Bypass Surgery Promises Remission of Type 2 Diabetes
The concept of offering bariatric surgery at a BMI lower than 35 has emerged as a viable option for individuals at high risk. As emerging data on safety and long-term efficacy emerges for bariatric surgery in this patient population.
Children with Obesity Tend to Become Adults who are Obese
Body mass index (BMI) is not necessarily an accurate measurement for overweight or obesity, since it does not distinguish lean mass from fat mass. An athlete, for example, may have a high BMI but is does not have obesity because his/her body weight is muscle.
7 Primary Causes of Obesity
Americans are gaining weight, and obesity has become a national health threat. We can’t place the problem purely on self-control. Why has obesity become such a weighty issue?
Vyvanse® Approved For Binge-Eating Disorder
The U.S. Food and Drug Administration (FDA) expanded the approved uses of Vyvanse® (lisdexamfetamine dimesylate) to include treatment of moderate-to-severe binge-eating disorder in adults, making it the first medication approved to treat this condition.
Alternatives to Medications That Cause Weight Gain
The guideline provides evidence to guide selection of agents with the least potential for weight gain or that promote weight loss when treating these conditions. The task force recommends using a shared decision-making process that includes information on expected weight gain when choosing pharmacotherapy.
Depression Is Common in Children with Obesity Who Attend Weight Management Programs
Approximately one-quarter to one-third of all children who have obesity and enter weight management programs are depressed, according to 2 studies.
Newly Approved Weight Loss Device Blocks the Vagus Nerve
VBLOC vagal blocking therapy delivered via the Maestro System is now approved to treat adults age 18 to 65 years with a body mass index (BMI) of 40 to 45 kg/m2 or >35 kg/m2 and 1 or more obesity-related complications.
Obesity and Health Consequences
While obesity is a disease in its own right, it poses a risk for the development of some other major health problems. Several obesity-related complications are explained.
Obesity and Cancer: Summary of the Position Statement of the American Society of Clinical Oncology (ASCO)—Introduction
The American Society of Clinical Oncology (ASCO) released a policy statement on initiatives to limit the harmful effects of obesity on cancer, and to prevent obesity-related cancers. Here, part 1 of this 2-part series presents an introduction to the topic and an overview of the position statement.
American Society of Clinical Oncology (ASCO): Initiatives to Reduce the Impact of Obesity on Cancer
The American Society of Clinical Oncology (ASCO) released a policy statement on initiatives to limit the harmful effects of obesity on cancer, and to prevent obesity-related cancers. Here, part 2 of this series summarizes ASCO’s 4-pronged approach to reduce the impact of obesity on cancer.
Pharmacological Management of Obesity: Agents and Mechanisms of Action
This article is the third in a 4-part series on the Endocrine Society’s clinical practice guideline on the pharmacological management of obesity. This section presents agents approved by the U.S. Food and Drug Administration (FDA) for the treatment of obesity and their mechanisms of action.
Adults with Obesity: Clinical Practice Guideline for Office Visits
This article is the second in a 4-part series on the Endocrine Society’s clinical practice guideline on the pharmacological management of obesity. This section presents steps to take during an office visit for adults with obesity.
Overview of the Endocrine Society's Guideline on Obesity Medications
This article is the first in a 4-part series on the Endocrine Society’s clinical practice guideline on the pharmacological management of obesity. This section presents an overview of the topic and the rationale for use of pharmacotherapy for chronic weight management.

Articles Reviewed by J. Michael Gonzalez-Campoy MD, PhD, FACE

Big Breakfast Beats Traditional 6-Meal Diabetes Diet
03/20/2018 - For those with type 2 diabetes mellitus, eating a bigger breakfast may promote weight loss and reduce hunger. See how it compares to the six-meal eating plan.
Is Weight Loss Surgery the Answer for Diabetes?
07/08/2015 - Weight loss surgery is better than intensive diet and physical activity alone for reversing type 2 diabetes with obesit, according to a small yet well-designed study that offers a head-to-head treatment study comparison.  
12 Weeks on a Strict Liquid Diet Program Reverses Diabetes
12/14/2017 - People who follow a limited calorie liquid meal replacement program for 12 weeks can reverse the diabetes, and stop the diabetes-related meds.
Severity of Diabetes Does Not Predict Usual Complications
12/05/2017 - Researchers confirmed that the severity of a person's diabetes appears unlikely to predict or dictate the rate or risk of developing commons complications such as heart disease, kidney problems, or neuropathy.
Bariatric Surgery Found Safe in Teenagers with Obesity
Bariatric surgery is increasingly being used to treat adolescents with severe obesity, despite limited data regarding the safety of these procedures in this age group. Now, the largest study on this topic shows that most teenagers that underwent bariatric surgery for weight loss had few short-term complications, as reported in "JAMA Pediatrics."

Financial Disclosures for J. Michael Gonzalez-Campoy MD, PhD, FACE

EndocrineWeb, a Remedy Health Media, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

Author's Statement

I, the undersigned, declare that neither I nor members of my immediate family have a financial interests or affiliation with commercial companies whose products and / or services may be mentioned in the materials I have authored, edited or reviewed for presentation on Remedy Health Media, LLC’s websites.
There are no disclosures for this author